Medical Treatments

Scientists are still studying whether the deworming medicine could have any effect on COVID-19. But the frenzy over the drug has far more to do with politics than science. Here's how that happened.

Lulu Garcia-Navarro speaks with Rosann Mariapurram, executive director of Jane's Due Process, a grassroots organization in Texas that helps people under 18 access abortion care.

NPR's Michel Martin speaks with former FDA scientist Luciana Borio about the decision by an FDA advisory panel to recommend Pfizer booster shots only for certain people at higher risk for COVID-19.

Kate Bilowitz moderates a Facebook group where people exchange views on vaccinations. She shares what moderating it has been like during the pandemic.

A Food and Drug Administration panel voted against giving most Americans a third Pfizer vaccine despite President Biden's plan to provide a COVID-19 booster to anyone over the age of 16.

India has sped up its COVID vaccination after a deadly spring outbreak. Half of those eligible have received at least one shot. But millions are still vulnerable as fears of a new wave loom.

An independent committee of experts has recommended that the Food and Drug Administration should not allow Pfizer to provide a third dose of its COVID-19 vaccine to Americans older than 16.

Patients with advanced cancer and heart disease are among those who have had to wait for surgeries and other procedures as critically ill, unvaccinated COVID patients strain the medical system.

The FDA is set to rule on Pfizer boosters on Friday. Some scientists say they aren't needed for healthy people and the doses would more helpful for the unvaccinated in countries with limited supplies.

Pfizer is seeking the FDA's permission to offer a third COVID-19 vaccine dose to those 16 and older. There's data that the vaccine's efficacy is waning and evidence that a booster can reverse that.

Pfizer says data supports its request for Food and Drug Administration approval of a third dose of the COVID-19 vaccine about six months after the second dose in people 16 years and older.